NUTRA PHARMA CORP (NPHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 150K 300K 450K Q2 '10: 157.7K Q3 '10: 359.9K Q4 '10: 50K Q1 '11: 120.3K Q2 '11: 279.2K Q3 '11: 251.8K Q1 '12: 14.9K Q2 '12: 16.3K Q3 '12: 13.2K Q4 '12: 158.8K Q1 '13: 22.6K Q2 '13: 20.3K Q3 '13: 38.9K Q4 '13: 23.1K Q1 '14: 54.8K Q2 '14: 98.9K Q3 '14: 275.1K Q4 '14: 165.8K Q1 '15: 121K Q2 '15: 78.1K Q3 '15: 52.9K Q4 '15: 39.4K Q1 '16: 37.4K Q2 '16: 30.7K Q3 '16: 70.5K Q4 '16: 29.8K Q1 '17: 17K Q2 '17: 33.2K Q3 '17: 38K Q4 '17: 32.8K Q1 '18: 32.5K Q2 '18: 29.4K Q3 '18: 44K Q4 '18: 26.3K Q1 '19: 41.3K Q2 '19: 10.2K Q3 '19: 42K Q4 '19: 10.9K Q1 '20: 17.1K Q2 '20: 6.2K Q3 '20: 13.4K Q4 '20: 15.2K Q1 '21: 22K Q2 '21: 30.5K Q3 '21: 19.3K Q4 '21: 26K Q1 '22: 13.8K Q2 '22: 28.4K Q3 '22: 24.6K Q4 '22: 79K Q1 '23: 54.5K Q2 '23: 52.4K Q3 '23: 51.6K Q4 '23: 47K Q1 '24: 37.7K Q2 '24: 51.7K Q3 '24: 75K Q4 '24: 81.9K Q1 '25: 74K Q2 '25: 84.5K Q3 '25: 70.2K Q4 '25: 28.9K Q1 '26: 27.2K Q2 '26: 34.5K Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Gross Profit Quarterly

-1.5M -1M -500K 0 500K 1M 1.5M Q2 '10: 94.8K Q3 '10: 255.9K Q4 '10: 2.9K Q1 '11: 88.7K Q2 '11: 217.6K Q3 '11: 163.4K Q4 '11: -1.2M Q1 '12: 11.9K Q2 '12: 12.9K Q3 '12: 9K Q4 '12: 21.8K Q1 '13: 15.3K Q2 '13: 4K Q3 '13: 32.7K Q4 '13: 11.7K Q1 '14: 46.7K Q2 '14: 81.9K Q3 '14: 224.7K Q4 '14: 126.8K Q1 '15: 95.9K Q2 '15: 58.4K Q3 '15: 40.3K Q4 '15: 30.8K Q1 '16: 29.9K Q2 '16: 20K Q3 '16: 60.6K Q1 '17: 9.2K Q2 '17: 22.2K Q3 '17: 33.7K Q4 '17: 29K Q1 '18: 26.6K Q2 '18: 12.8K Q3 '18: 6.6K Q1 '19: 25.7K Q2 '19: 6.4K Q3 '19: 35.5K Q1 '20: 11.8K Q2 '20: 2.6K Q3 '20: 10.3K Q1 '21: 16.4K Q2 '21: 21.5K Q3 '21: 9.6K Q1 '22: 7.8K Q2 '22: 29.6K Q3 '22: 68.2K Q4 '22: 143.5K Q1 '23: 103.1K Q2 '23: 84.6K Q3 '23: 115K Q4 '23: 93.7K Q1 '24: 35.2K Q2 '24: 54.8K Q3 '24: 70.7K Q4 '24: 86.6K Q1 '25: 59.1K Q2 '25: 63.4K Q3 '25: 64.6K Q4 '25: 9.5K Q1 '26: 19K Q2 '26: 32.6K Q1 '11 Q1 '13 Q1 '15 Q2 '17 Q3 '19 Q2 '22 Q2 '24 Q2 '26

Operating Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q1 '10: -300.8K Q2 '10: -1.4M Q3 '10: -690.7K Q4 '10: -1.1M Q1 '11: -618.2K Q2 '11: -637.5K Q3 '11: -668.9K Q4 '11: -2M Q1 '12: -725.9K Q2 '12: -183K Q3 '12: -205K Q4 '12: -1.6M Q1 '13: -331.8K Q2 '13: -358.4K Q3 '13: -544.4K Q4 '13: -1.1M Q1 '14: -227.9K Q2 '14: -640.7K Q3 '14: -522.8K Q4 '14: -810.8K Q1 '15: -292.8K Q2 '15: -996.1K Q3 '15: -3.9M Q4 '15: -560.6K Q1 '16: -354.6K Q2 '16: -608.8K Q3 '16: -506K Q4 '16: -574.1K Q1 '17: -418K Q2 '17: -415.4K Q3 '17: -273.5K Q4 '17: -274.9K Q1 '18: -337.5K Q2 '18: -335.8K Q3 '18: -854.3K Q4 '18: -351.3K Q1 '19: -248.9K Q2 '19: -327.8K Q3 '19: -235.2K Q4 '19: -417.9K Q1 '20: -187.1K Q2 '20: -198.9K Q3 '20: -183.8K Q4 '20: -355.2K Q1 '21: -541.2K Q2 '21: -438.7K Q3 '21: -512.3K Q4 '21: -496.2K Q1 '22: -308.4K Q2 '22: -341.1K Q3 '22: -236.5K Q4 '22: -1M Q1 '23: -398.7K Q2 '23: -182.3K Q3 '23: -165.8K Q4 '23: -140.2K Q1 '24: -295.3K Q2 '24: -219.5K Q3 '24: -184.8K Q4 '24: -178.9K Q1 '25: -349.8K Q2 '25: -290.5K Q3 '25: -356.1K Q4 '25: -465.9K Q1 '26: -379.2K Q2 '26: -435.5K Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q1 '10: -300.8K Q2 '10: -1.4M Q3 '10: -640.7K Q4 '10: -765.2K Q1 '11: -638.2K Q2 '11: -598K Q3 '11: -661.8K Q4 '11: -2.5M Q1 '12: -1.1M Q2 '12: -134.3K Q3 '12: -302.8K Q4 '12: -2.2M Q1 '13: -473.3K Q2 '13: -609.1K Q3 '13: -2.6M Q4 '13: -613.7K Q1 '14: -206.9K Q2 '14: -1.3M Q3 '14: -205K Q4 '14: -802.1K Q1 '15: -364K Q2 '15: -1.8M Q3 '15: -3.9M Q4 '15: 676.1K Q1 '16: -1.1M Q2 '16: -653.9K Q3 '16: -644K Q4 '16: -1.1M Q1 '17: -940.1K Q2 '17: -1.1M Q3 '17: -981.4K Q4 '17: -991.9K Q1 '18: -997.6K Q2 '18: -1.3M Q3 '18: -967.9K Q4 '18: -588.5K Q1 '19: -400.4K Q2 '19: -1.7M Q3 '19: -487.1K Q4 '19: -4M Q1 '20: 2.2M Q2 '20: -1.5M Q3 '20: 587.8K Q4 '20: -2M Q1 '21: -34M Q2 '21: 3.4M Q3 '21: 15.4M Q4 '21: 2.1M Q1 '22: 5M Q2 '22: -645.8K Q3 '22: 577.2K Q4 '22: 3.2M Q1 '23: -592.6K Q2 '23: -279.2K Q3 '23: -278.5K Q4 '23: -243.1K Q1 '24: -426.9K Q2 '24: -367.1K Q3 '24: -260.7K Q4 '24: -230.9K Q1 '25: -1.4M Q2 '25: 369.6K Q3 '25: -523.5K Q4 '25: -488.5K Q1 '26: -459.7K Q2 '26: -3.9M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 250K 500K 750K Q2 '10: 62.9K Q3 '10: 104.1K Q4 '10: 47.1K Q1 '11: 31.5K Q2 '11: 61.5K Q3 '11: 88.5K Q4 '11: 698K Q1 '12: 3K Q2 '12: 3.4K Q3 '12: 4.3K Q4 '12: 137K Q1 '13: 7.3K Q2 '13: 16.4K Q3 '13: 6.2K Q4 '13: 11.4K Q1 '14: 8K Q2 '14: 17K Q3 '14: 50.4K Q4 '14: 39K Q1 '15: 25.1K Q2 '15: 19.6K Q3 '15: 12.5K Q4 '15: 8.6K Q1 '16: 7.5K Q2 '16: 10.7K Q3 '16: 9.9K Q4 '16: 10.8K Q1 '17: 7.8K Q2 '17: 11K Q3 '17: 4.3K Q4 '17: 3.8K Q1 '18: 5.9K Q2 '18: 16.6K Q3 '18: 37.4K Q4 '18: 10.4K Q1 '19: 15.6K Q2 '19: 3.8K Q3 '19: 6.5K Q1 '20: 5.3K Q2 '20: 3.7K Q3 '20: 3.1K Q1 '21: 5.6K Q2 '21: 9K Q3 '21: 9.6K Q4 '21: 17K Q1 '22: 14.4K Q2 '22: 60.8K Q3 '22: 41.1K Q4 '22: 46.6K Q1 '23: 51.9K Q2 '23: 80.3K Q3 '23: 24.8K Q4 '23: 20.5K Q1 '24: 22.5K Q2 '24: 18.6K Q3 '24: 23.8K Q4 '24: 19.9K Q1 '25: 46.3K Q2 '25: 58.7K Q3 '25: 34.1K Q4 '25: 66K Q1 '26: 29.2K Q2 '26: 25.3K Q4 '11 Q4 '13 Q4 '15 Q4 '17 Q1 '20 Q2 '22 Q2 '24 Q2 '26

Operating Cash Flow Quarterly

-1.1M -700K -350K 0 350K 700K 1.1M Q3 '10: -379.4K Q4 '10: -142.2K Q1 '11: -455.4K Q2 '11: -570.8K Q3 '11: -886.4K Q4 '11: 24.5K Q1 '12: -198.1K Q2 '12: -77.1K Q3 '12: -294.3K Q4 '12: -151.7K Q1 '13: -64.1K Q2 '13: -101K Q3 '13: -251.6K Q4 '13: -114.4K Q1 '14: -90.5K Q2 '14: 21.9K Q3 '14: -22.1K Q4 '14: -57.4K Q1 '15: -117K Q2 '15: -502.4K Q3 '15: -208.4K Q4 '15: -190.4K Q1 '16: -265.7K Q2 '16: -283.1K Q3 '16: -419.3K Q4 '16: -388.3K Q1 '17: -371.5K Q2 '17: -295.8K Q3 '17: -244.7K Q4 '17: -226.4K Q1 '18: -348.3K Q2 '18: -352.7K Q3 '18: -162.9K Q4 '18: -136K Q1 '19: -91.5K Q2 '19: -192.2K Q3 '19: -151.2K Q4 '19: -308.7K Q1 '20: -215.6K Q2 '20: -172.7K Q3 '20: -137.1K Q4 '20: -352.8K Q1 '21: -594.3K Q2 '21: -503.5K Q3 '21: -412.9K Q4 '21: -233.7K Q1 '22: -258.2K Q2 '22: -284.8K Q3 '22: -165.3K Q4 '22: -54K Q1 '23: -92.8K Q2 '23: -186.8K Q3 '23: -84.2K Q4 '23: -186.2K Q1 '24: -171.2K Q2 '24: -93.6K Q3 '24: 19.1K Q4 '24: -178.2K Q1 '25: -405K Q2 '25: -288.4K Q3 '25: -250.8K Q4 '25: -219.8K Q1 '26: -327.8K Q2 '26: -251.2K Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-1.1M -700K -350K 0 350K 700K 1.1M Q3 '10: -382.9K Q4 '10: -286.2K Q3 '11: -888.4K Q4 '11: 24.2K Q1 '12: -198.1K Q2 '12: -77.1K Q3 '12: -294.3K Q4 '12: -151.7K Q1 '13: -64.1K Q4 '14: -58.8K Q1 '15: -117.7K Q2 '15: -502.4K Q3 '15: -208.4K Q4 '15: -190.4K Q4 '16: -390.8K Q1 '21: -604.3K Q2 '21: -523.8K Q3 '21: -417.5K Q4 '21: -238K Q1 '22: -316.2K Q2 '22: -284.8K Q3 '22: -165.3K Q4 '22: -54K Q1 '25: -431.1K Q2 '25: -288.4K Q3 '25: -250.8K Q4 '25: -219.8K Q3 '11 Q3 '12 Q1 '15 Q4 '16 Q4 '21 Q4 '22 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15B 30B 45B Q1 '19: 4.1B Q2 '19: 4.6B Q3 '19: 5.1B Q1 '20: 12.3B Q2 '20: 6.6B Q3 '20: 13.1B Q1 '21: 7.1B Q2 '21: 11.8B Q3 '21: 12.7B Q1 '22: 14.5B Q2 '22: 7.5B Q3 '22: 15.6B Q1 '23: 7.6B Q2 '23: 7.6B Q3 '23: 7.6B Q1 '24: 7.6B Q2 '24: 7.7B Q3 '24: 7.7B Q1 '25: 7.7B Q2 '25: 37.7B Q3 '25: 7.8B Q1 '26: 8B Q2 '26: 8.1B Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.15 -0.10 -0.05 0.00 0.05 0.10 0.15 Q4 '10: -0.01 Q1 '11: 0.00 Q2 '11: 0.00 Q3 '11: 0.00 Q4 '11: 0.00 Q1 '12: 0.00 Q2 '12: 0.00 Q3 '12: 0.00 Q4 '12: -0.01 Q1 '13: -0.01 Q2 '13: -0.01 Q3 '13: -0.01 Q4 '13: 0.00 Q1 '14: 0.00 Q2 '14: -0.05 Q3 '14: -0.06 Q4 '14: -0.08 Q1 '15: -0.09 Q2 '15: -0.08 Q3 '15: -0.01 Q4 '15: -0.10 Q1 '16: -0.10 Q2 '16: -0.07 Q3 '16: -0.13 Q4 '16: -0.02 Q1 '17: -0.03 Q2 '17: -0.02 Q3 '17: -0.02 Q4 '17: 0.00 Q1 '18: 0.02 Q2 '18: 0.02 Q3 '18: 0.02 Q4 '18: 0.00 Q1 '19: 0.00 Q2 '19: 0.00 Q3 '19: 0.00 Q4 '19: 0.00 Q1 '20: 0.00 Q2 '20: 0.00 Q3 '20: 0.00 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: 0.00 Q4 '21: 0.00 Q1 '22: 0.00 Q2 '22: 0.00 Q3 '22: 0.00 Q4 '22: 0.00 Q1 '23: 0.00 Q2 '23: 0.00 Q3 '23: 0.00 Q4 '23: 0.00 Q1 '24: 0.00 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.00 Q3 '25: 0.00 Q4 '25: 0.00 Q1 '26: 0.00 Q2 '26: 0.00 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.